Suppr超能文献

化脓性汗腺炎:一种针对古老疾病的新治疗方法。

Hidradenitis suppurativa: a new therapeutic approach for an old disease.

作者信息

Billewicz Marta, Wojtania Joanna, Woźniacka Anna

机构信息

Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland.

出版信息

Postepy Dermatol Alergol. 2024 Aug;41(4):350-356. doi: 10.5114/ada.2024.142185. Epub 2024 Aug 12.

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory disease characterised by recurrent painful nodules, abscesses, fistulas and scarring. The primary distinguishing factor in the complex, yet still not fully understood, pathogenesis is an inflammation occurring within the hair follicle, followed by an immune response leading to further development of the skin lesions seen in HS. The treatment of patients with HS is very difficult due to the complexity of the lesions and the frequent tendency to recurrence, which also has a negative impact on the psychological state of patients and directly translates into a reduced quality of life. This review article addresses the pathogenesis, clinical presentation of HS and, in particular, explores the new therapeutic options available.

摘要

化脓性汗腺炎(HS)是一种慢性炎症性疾病,其特征为反复发作的疼痛性结节、脓肿、瘘管和瘢痕形成。在其复杂但仍未完全理解的发病机制中,主要的区别因素是毛囊内发生的炎症,随后引发免疫反应,导致HS中所见皮肤病变的进一步发展。由于病变的复杂性和频繁复发的倾向,HS患者的治疗非常困难,这也对患者的心理状态产生负面影响,并直接导致生活质量下降。这篇综述文章阐述了HS的发病机制、临床表现,尤其探讨了现有的新治疗选择。

相似文献

1
Hidradenitis suppurativa: a new therapeutic approach for an old disease.
Postepy Dermatol Alergol. 2024 Aug;41(4):350-356. doi: 10.5114/ada.2024.142185. Epub 2024 Aug 12.
3
New perspectives on the treatment of hidradenitis suppurativa.
Ther Adv Chronic Dis. 2021 Nov 23;12:20406223211055920. doi: 10.1177/20406223211055920. eCollection 2021.
4
[Hidradenitis suppurativa/acne inversa: An update].
Hautarzt. 2015 Jun;66(6):413-22. doi: 10.1007/s00105-015-3616-y.
5
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
J Dtsch Dermatol Ges. 2024 Jun;22(6):868-889. doi: 10.1111/ddg.15412. Epub 2024 May 21.
7
Hidradenitis suppurativa: a review of current treatment options.
Int J Dermatol. 2022 Sep;61(9):1152-1164. doi: 10.1111/ijd.16115. Epub 2022 Feb 6.
8
Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations.
Int J Mol Sci. 2022 Aug 26;23(17):9716. doi: 10.3390/ijms23179716.
9
Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.
Antibiotics (Basel). 2024 Mar 17;13(3):268. doi: 10.3390/antibiotics13030268.
10
[Acne inversa].
Hautarzt. 2010 Jan;61(1):39-46. doi: 10.1007/s00105-009-1813-2.

本文引用的文献

1
Successful treatment of Hidradenitis Suppurativa with tofacitinib: two cases and a review of the literature.
Oxf Med Case Reports. 2023 Mar 25;2023(3):omad003. doi: 10.1093/omcr/omad003. eCollection 2023 Mar.
3
Stress signalling and STAT1 activation characterize the keratinocytic gene expression pattern in Hidradenitis suppurativa.
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2488-2498. doi: 10.1111/jdv.18465. Epub 2022 Aug 9.
7
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.
Front Immunol. 2020 Nov 17;11:594735. doi: 10.3389/fimmu.2020.594735. eCollection 2020.
8
Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa.
Int J Dermatol. 2021 Feb;60(2):217-221. doi: 10.1111/ijd.15124. Epub 2020 Aug 17.
10
Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases).
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e750-e751. doi: 10.1111/jdv.16605. Epub 2020 Jun 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验